Scholarlink

Objective <p>The pathogenesis of convexal subarachnoid haemorrhage (cSAH) remains unclear. Investigating the role of cerebral blood flow (CBF) perfusion in cSAH holds clinical value.</p> Methods <p>We retrospectively reviewed the clinical, laboratory, and preoperative computed tomography perfusion (CTP) or arterial spin labelling data of patients who underwent angioplasty for flow-restricting head and neck artery lesions at four centres (2021–2024). A standardised protocol was used for multi-slice region of interest analysis in watershed regions to calculate the affected/unaffected perfusion ratio. Firth’s penalised-likelihood regression identified independent cSAH risk factors, and model utility was assessed by decision curve analysis.</p> Results <p>Postoperative cSAH occurred in 41 of 3967 patients (1.0%). Analysis of 111 patients (21 with cSAH, 90 without intracranial haemorrhage [ICH]) revealed that the cSAH group had significantly higher preoperative watershed relative CBF (rCBF) in global anterior, posterior, and overall regions (all <i>P</i> &lt; 0.05). Multivariable analysis identified preoperative watershed rCBF ≥ 1.1 (odds ratio [OR] 9.20, 95% confidence interval [CI] 2.58–40.23; <i>P</i> &lt; 0.001) and prolonged prothrombin time (PT) (OR 3.21, 95% CI 1.69–7.44; <i>P</i> &lt; 0.001) as independent risk factors. Higher mean platelet volume (MPV) was protective (OR 0.47, 95% CI 0.20–0.99; <i>P</i> = 0.046). The prediction model (corrected area under the curve 0.882) provided net clinical benefit. cSAH did not affect 90-day outcomes (<i>P</i> = 0.198).</p> Conclusion <p>Following flow-restricting angioplasty, the cSAH rate was approximately 1%. Preoperative watershed hyperperfusion was a key predictor. Prolonged PT increased cSAH risk, whereas elevated MPV was protective. With appropriate management, cSAH may not worsen prognosis.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The predictive value of cerebral blood flow perfusion for cSAH following flow-restricting head and neck artery angioplasty

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月15日

查看全文
  • Fangcun Li,
  • Lili Zhao,
  • Wei Huang,
  • Dun Ding,
  • Jialiang Lu,
  • Fan Tang,
  • Fude Liu,
  • Hui Lei,
  • Nannan Han,
  • Ye Li,
  • Yating Jian,
  • Ziwei Lu,
  • Tao Li,
  • Meijuan Dang,
  • Xiaoya Wang,
  • Lei Zhang,
  • Mingze Chang,
  • Hong Fan,
  • Guilian Zhang

摘要

Objective

The pathogenesis of convexal subarachnoid haemorrhage (cSAH) remains unclear. Investigating the role of cerebral blood flow (CBF) perfusion in cSAH holds clinical value.

Methods

We retrospectively reviewed the clinical, laboratory, and preoperative computed tomography perfusion (CTP) or arterial spin labelling data of patients who underwent angioplasty for flow-restricting head and neck artery lesions at four centres (2021–2024). A standardised protocol was used for multi-slice region of interest analysis in watershed regions to calculate the affected/unaffected perfusion ratio. Firth’s penalised-likelihood regression identified independent cSAH risk factors, and model utility was assessed by decision curve analysis.

Results

Postoperative cSAH occurred in 41 of 3967 patients (1.0%). Analysis of 111 patients (21 with cSAH, 90 without intracranial haemorrhage [ICH]) revealed that the cSAH group had significantly higher preoperative watershed relative CBF (rCBF) in global anterior, posterior, and overall regions (all P < 0.05). Multivariable analysis identified preoperative watershed rCBF ≥ 1.1 (odds ratio [OR] 9.20, 95% confidence interval [CI] 2.58–40.23; P < 0.001) and prolonged prothrombin time (PT) (OR 3.21, 95% CI 1.69–7.44; P < 0.001) as independent risk factors. Higher mean platelet volume (MPV) was protective (OR 0.47, 95% CI 0.20–0.99; P = 0.046). The prediction model (corrected area under the curve 0.882) provided net clinical benefit. cSAH did not affect 90-day outcomes (P = 0.198).

Conclusion

Following flow-restricting angioplasty, the cSAH rate was approximately 1%. Preoperative watershed hyperperfusion was a key predictor. Prolonged PT increased cSAH risk, whereas elevated MPV was protective. With appropriate management, cSAH may not worsen prognosis.